On September 2, 2020 Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, reported that company management will participate in the following upcoming investor conferences (Press release, Personalis, SEP 2, 2020, View Source [SID1234564340]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C. Wainwright 22nd Annual Global Investment Conference
Presenting on Wednesday, September 16 at 11 a.m. Eastern Time
Morgan Stanley 18th Annual Global Healthcare Conference
Fireside chat on Thursday, September 17 at 3:30 p.m. Eastern Time
Cowen’s Liquid Biopsy Summit
Presenting on Thursday, September 24 at 2:30 p.m. Eastern Time